https://www.selleckchem.com/pr....oducts/vorolanib.htm
There is a paucity of data regarding acute phase (in-hospital and 30-day) major adverse cardiac events (MACE) following ST-segment elevation myocardial infarction (STEMI) in Bangladesh. This study aimed to document MACE during the acute phase post-STEMI to provide information. We enrolled STEMI patients of the National Institute of Cardiovascular Disease, Dhaka, Bangladesh, from August 2017 to October 2018 and followed up through 30days post-discharge for MACE, defined as the composite of all-cause death, myocardial infarction, and co
Gefällt mir
Kommentar
Teilen
